175 related articles for article (PubMed ID: 36710498)
1. The incidence and characteristics of giant cell arteritis in Hispanics and the associated outcomes of ischemic ocular events and stroke.
Smith LM; Alvarado LA; Dihowm F
J Investig Med; 2023 Apr; 71(4):411-418. PubMed ID: 36710498
[TBL] [Abstract][Full Text] [Related]
2. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
4. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
Hernández-Rodríguez J; Font C; García-Martínez A; Espígol-Frigolé G; Sanmartí R; Cañete JD; Grau JM; Cid MC
Medicine (Baltimore); 2007 Jul; 86(4):233-241. PubMed ID: 17632265
[TBL] [Abstract][Full Text] [Related]
5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
6. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
7. Treatment and Outcomes of Acute Myocardial Infarction in Patients With Polymyalgia Rheumatica With and Without Giant Cell Arteritis.
Sokhal BS; Matetić A; Bharadwaj A; Helliwell T; Abhishek A; Mallen CD; Mohamed MO; Mamas MA
Am J Cardiol; 2022 Jul; 174():12-19. PubMed ID: 35473781
[TBL] [Abstract][Full Text] [Related]
8. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
[TBL] [Abstract][Full Text] [Related]
9. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations of diagnosis and treatment of giant cell arteritis and polymyalgia rheumatic in China].
Wang P; Feng XB; Duan XW; Liu SY; Zhao Y
Zhonghua Nei Ke Za Zhi; 2023 Mar; 62(3):256-266. PubMed ID: 36822851
[TBL] [Abstract][Full Text] [Related]
11. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
12. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
Becker M
Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
[TBL] [Abstract][Full Text] [Related]
13. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
Gutteridge DH; Mastaglia FL
Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265
[TBL] [Abstract][Full Text] [Related]
14. Giant cell arteritis and polymyalgia rheumatica: an update.
González-Gay MA; Pina T
Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
[TBL] [Abstract][Full Text] [Related]
16. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
Pujades-Rodriguez M; Duyx B; Thomas SL; Stogiannis D; Smeeth L; Hemingway H
Heart; 2016 Mar; 102(5):383-9. PubMed ID: 26786818
[TBL] [Abstract][Full Text] [Related]
17. The Spectrum of Pericardial Involvement in Giant Cell Arteritis and Polymyalgia Rheumatica: A Systematic Review of Literature.
Fayyaz B; Rehman HJ
J Clin Rheumatol; 2021 Jan; 27(1):5-10. PubMed ID: 31483352
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and significance of ischemic cerebrovascular events in giant cell arteritis.
Coronel L; Rodríguez-Pardo J; Monjo I; de Miguel E
Med Clin (Barc); 2021 Jul; 157(2):53-57. PubMed ID: 32826078
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
20. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
